ArticleJAAD case reports2024

Successful treatment of pityriasis rubra pilaris with brodalumab after nonresponse to IL-17A inhibition: A role for the innate cytokine IL-17C.

Kailyn Valido et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.